Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-007672
Filing Date
2022-02-28
Accepted
2022-02-28 17:08:48
Documents
114
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avir-10k_20211231.htm   iXBRL 10-K 3324008
2 EX-10.1.1 avir-ex1011_322.htm EX-10.1.1 66084
3 EX-10.1.2 avir-ex1012_323.htm EX-10.1.2 67399
4 EX-10.3 avir-ex103_792.htm EX-10.3 22345
5 EX-10.5 avir-ex105_908.htm EX-10.5 1672889
6 EX-21.1 avir-ex211_13.htm EX-21.1 5021
7 EX-23.1 avir-ex231_9.htm EX-23.1 3043
8 EX-31.1 avir-ex311_10.htm EX-31.1 20940
9 EX-31.2 avir-ex312_6.htm EX-31.2 20944
10 EX-32.1 avir-ex321_14.htm EX-32.1 10460
11 EX-32.2 avir-ex322_11.htm EX-32.2 10760
12 GRAPHIC gyr1b3rilflf000012.jpg GRAPHIC 1195
13 GRAPHIC gyr1b3rilflf000015.jpg GRAPHIC 46492
14 GRAPHIC gyr1b3rilflf000011.jpg GRAPHIC 121576
15 GRAPHIC gyr1b3rilflf000026.jpg GRAPHIC 50071
16 GRAPHIC gyr1b3rilflf000014.jpg GRAPHIC 68974
17 GRAPHIC g4wnpoc2tref000003.jpg GRAPHIC 1547
18 GRAPHIC gyr1b3rilflf000001.jpg GRAPHIC 81518
19 GRAPHIC gyr1b3rilflf000008.jpg GRAPHIC 53541
20 GRAPHIC gyr1b3rilflf000003.jpg GRAPHIC 169127
21 GRAPHIC gyr1b3rilflf000023.jpg GRAPHIC 30929
22 GRAPHIC gyr1b3rilflf000017.jpg GRAPHIC 226257
23 GRAPHIC gyr1b3rilflf000010.jpg GRAPHIC 34986
24 GRAPHIC gyr1b3rilflf000024.jpg GRAPHIC 37312
25 GRAPHIC g4wnpoc2tref000014.jpg GRAPHIC 1452
26 GRAPHIC g4wnpoc2tref000004.jpg GRAPHIC 4221
27 GRAPHIC gyr1b3rilflf000020.jpg GRAPHIC 46676
28 GRAPHIC gyr1b3rilflf000022.jpg GRAPHIC 50678
29 GRAPHIC gyr1b3rilflf000005.jpg GRAPHIC 96451
30 GRAPHIC gyr1b3rilflf000006.jpg GRAPHIC 84482
31 GRAPHIC gyr1b3rilflf000025.jpg GRAPHIC 38145
32 GRAPHIC g4wnpoc2tref000002.jpg GRAPHIC 1547
33 GRAPHIC gyr1b3rilflf000016.jpg GRAPHIC 65151
34 GRAPHIC g4wnpoc2tref000013.jpg GRAPHIC 1520
35 GRAPHIC gyr1b3rilflf000019.jpg GRAPHIC 46845
36 GRAPHIC gyr1b3rilflf000002.jpg GRAPHIC 153305
37 GRAPHIC gyr1b3rilflf000007.jpg GRAPHIC 113714
38 GRAPHIC g4wnpoc2tref000001.jpg GRAPHIC 4221
39 GRAPHIC gyr1b3rilflf000013.jpg GRAPHIC 63942
40 GRAPHIC gyr1b3rilflf000018.jpg GRAPHIC 400846
41 GRAPHIC gyr1b3rilflf000004.jpg GRAPHIC 143910
42 GRAPHIC gyr1b3rilflf000009.jpg GRAPHIC 96642
43 GRAPHIC gyr1b3rilflf000021.jpg GRAPHIC 41406
  Complete submission text file 0001564590-22-007672.txt   17445742

Data Files

Seq Description Document Type Size
44 XBRL TAXONOMY EXTENSION SCHEMA avir-20211231.xsd EX-101.SCH 56411
45 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avir-20211231_cal.xml EX-101.CAL 45366
46 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avir-20211231_def.xml EX-101.DEF 173327
47 XBRL TAXONOMY EXTENSION LABEL LINKBASE avir-20211231_lab.xml EX-101.LAB 449208
48 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avir-20211231_pre.xml EX-101.PRE 352348
108 EXTRACTED XBRL INSTANCE DOCUMENT avir-10k_20211231_htm.xml XML 1414893
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39661 | Film No.: 22691232
SIC: 2834 Pharmaceutical Preparations